MediPharm Labs (TSE:LABS) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MediPharm Labs reported a significant improvement in its financial results for the third quarter, with net revenue rising by 15% and gross profit improving by 29% compared to the previous year. The company has also paid off all its convertible debt, allowing it to focus on expanding in international markets, particularly Germany and Australia, where it has seen substantial growth.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.